{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:04:56Z","timestamp":1784275496727,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-026-06217-x","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:09:24Z","timestamp":1783148964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Frequency and clinical characteristics of hydroxychloroquine-induced pigmentation in Japanese paediatric patients: a retrospective cohort study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3197-5719","authenticated-orcid":false,"given":"Reiko","family":"Yatabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2682-9020","authenticated-orcid":false,"given":"Keiji","family":"Akamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1768-9927","authenticated-orcid":false,"given":"Shogo","family":"Akahoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8109-8135","authenticated-orcid":false,"given":"Satoru","family":"Mizumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6642-7283","authenticated-orcid":false,"given":"Naoki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4155-7174","authenticated-orcid":false,"given":"Naoaki","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7151-459X","authenticated-orcid":false,"given":"Riku","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"4","key":"6217_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3892\/mmr.2025.13467","volume":"31","author":"R Huo","year":"2025","unstructured":"Huo R, Wei C, Yang Y, Lin J, Huang X (2025) Hydroxychloroquine: A double\u2013edged sword (Review). Mol Med Rep 31(4):102. https:\/\/doi.org\/10.3892\/mmr.2025.13467","journal-title":"Mol Med Rep"},{"issue":"12","key":"6217_CR2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41584-018-0111-8","volume":"14","author":"A Jorge","year":"2018","unstructured":"Jorge A, Ung C, Young LH, Melles RB, Choi HK (2018) Hydroxychloroquine retinopathy - implications of research advances for rheumatology care. Nat Rev Rheumatol 14(12):693\u2013703. https:\/\/doi.org\/10.1038\/s41584-018-0111-8","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"6217_CR3","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","volume":"132","author":"RB Melles","year":"2014","unstructured":"Melles RB, Marmor MF (2014) The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol 132(12):1453\u20131460. https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.3459","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"6217_CR4","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/rheumatology\/keae217","volume":"64","author":"ZJ Yin","year":"2025","unstructured":"Yin ZJ, Li P, Yu J, Zuo D, Fan H, Li F et al (2025) Hydroxychloroquine-induced pigmentation in rheumatic diseases: prevalence, clinical features and influencing factors. Rheumatology (Oxford) 64(3):985\u2013993. https:\/\/doi.org\/10.1093\/rheumatology\/keae217","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"6217_CR5","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1001\/jamadermatol.2013.709","volume":"149","author":"M Jallouli","year":"2013","unstructured":"Jallouli M, Frances C, Piette JC, Huong du LT, Moguelet P, Factor C et al (2013) Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study. JAMA Dermatol 149(8):935\u2013940. https:\/\/doi.org\/10.1001\/jamadermatol.2013.709","journal-title":"JAMA Dermatol"},{"issue":"7","key":"6217_CR6","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s00296-021-04868-6","volume":"41","author":"R Muller","year":"2021","unstructured":"Muller R (2021) Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities. Rheumatol Int 41(7):1189\u20131202. https:\/\/doi.org\/10.1007\/s00296-021-04868-6","journal-title":"Rheumatol Int"},{"issue":"11","key":"6217_CR7","doi-asserted-by":"publisher","first-page":"e29044","DOI":"10.1097\/md.0000000000029044","volume":"101","author":"PUJ Silva","year":"2022","unstructured":"Silva PUJ, Oliveira MB, Vieira W, Cardoso SV, Blumenberg C, Franco A et al (2022) Oral pigmentation as an adverse effect of chloroquine and hydroxychloroquine use: A scoping review. Med (Baltim) 101(11):e29044. https:\/\/doi.org\/10.1097\/md.0000000000029044","journal-title":"Med (Baltim)"},{"issue":"6","key":"6217_CR8","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1001\/archderm.124.6.869","volume":"124","author":"TB Fitzpatrick","year":"1988","unstructured":"Fitzpatrick TB (1988) The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124(6):869\u2013871. https:\/\/doi.org\/10.1001\/archderm.124.6.869","journal-title":"Arch Dermatol"},{"key":"6217_CR9","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2020-5-8","author":"AK Leung","year":"2020","unstructured":"Leung AK, McMillan T, Human A, Lam JM (2020) Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus. Drugs Context. https:\/\/doi.org\/10.7573\/dic.2020-5-8. 9:2020-5-8","journal-title":"Drugs Context"},{"key":"6217_CR10","first-page":"929","volume":"43","author":"J Barr","year":"1944","unstructured":"Barr J (1944) Subungual pigmentation following prolonged atabrine therapy. U S Naval Med Bull 43:929","journal-title":"U S Naval Med Bull"},{"key":"6217_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4269\/ajtmh.1945.s1-25.469","volume":"25","author":"VW Lippard","year":"1945","unstructured":"Lippard VW, Kauer GL Jr (1945) Pigmentation of the palate and subungual tissues associated with suppressive quinacrine hydrochloride therapy. Am J Trop Med Hyg 25:469\u2013471. https:\/\/doi.org\/10.4269\/ajtmh.1945.s1-25.469","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"6217_CR12","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1177\/0961203317700486","volume":"26","author":"E Bahloul","year":"2017","unstructured":"Bahloul E, Jallouli M, Garbaa S, Marzouk S, Masmoudi A, Turki H et al (2017) Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases. Lupus 26(12):1304\u20131308. https:\/\/doi.org\/10.1177\/0961203317700486","journal-title":"Lupus"},{"key":"6217_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.04.007","author":"K Hur","year":"2021","unstructured":"Hur K, Kwak Y, Lee SH (2021) Hydroxychloroquine-associated pigmentation after extravasation injury. JAAD Case Rep. https:\/\/doi.org\/10.1016\/j.jdcr.2021.04.007. 12:46\u2009\u2013\u20098","journal-title":"JAAD Case Rep"},{"issue":"2","key":"6217_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jaad.2020.04.024","volume":"83","author":"AN Sharma","year":"2020","unstructured":"Sharma AN, Mesinkovska NA, Paravar T (2020) Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic review. J Am Acad Dermatol 83(2):563\u2013578. https:\/\/doi.org\/10.1016\/j.jaad.2020.04.024","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"6217_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1600-0714.1986.tb00660.x","volume":"15","author":"NW Savage","year":"1986","unstructured":"Savage NW, Barber MT, Adkins KF (1986) Pigmentary changes in rat oral mucosa following antimalarial therapy. J Oral Pathol 15(9):468\u2013471. https:\/\/doi.org\/10.1111\/j.1600-0714.1986.tb00660.x","journal-title":"J Oral Pathol"},{"issue":"2","key":"6217_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1067\/moe.2000.106340","volume":"90","author":"CL Kleinegger","year":"2000","unstructured":"Kleinegger CL, Hammond HL, Finkelstein MW (2000) Oral mucosal hyperpigmentation secondary to antimalarial drug therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90(2):189\u2013194. https:\/\/doi.org\/10.1067\/moe.2000.106340","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"3","key":"6217_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","volume":"16","author":"E Schrezenmeier","year":"2020","unstructured":"Schrezenmeier E, Dorner T (2020) Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 16(3):155\u2013166. https:\/\/doi.org\/10.1038\/s41584-020-0372-x","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"6217_CR18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40257-021-00633-4","volume":"22","author":"N Elbuluk","year":"2021","unstructured":"Elbuluk N, Grimes P, Chien A, Hamzavi I, Alexis A, Taylor S et al (2021) The Pathogenesis and Management of Acne-Induced Post-inflammatory Hyperpigmentation. Am J Clin Dermatol 22(6):829\u2013836. https:\/\/doi.org\/10.1007\/s40257-021-00633-4","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"6217_CR19","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/rheumatology\/keab352","volume":"61","author":"R Muller","year":"2022","unstructured":"Muller R, Jarrot PA, Kaplanski G (2022) Hydroxychloroquine-related hyperpigmentation. Rheumatology (Oxford) 61(2):873. https:\/\/doi.org\/10.1093\/rheumatology\/keab352","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06217-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06217-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06217-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:17:13Z","timestamp":1784272633000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-026-06217-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":19,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["6217"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06217-x","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"186"}}